Eleuterio Ferrannini, MD; Dr. Diamant; Dr. Barnett; Dr. Davies, PhD; Dr. Hanefeld, PhDCME Released: 10/24/2011; Valid for credit through 10/24/2012 Despite the availability of multiple pharmacologic agents, the treatment of patients with type 2 Diabetes mellitus remains suboptimal. Given the disease's high and increasing prevalence, the morbidity, mortality, and economic consequences of type 2